Doctors Hesitant to Intervene in Addiction Treatment, Citing Institutional Environment Barriers

Despite the growing need for substance use disorder (SUD) treatment, physicians remain reluctant to treat addiction. That’s according to a new systematic review published in JAMA, which included a total of 283 articles. Researchers found that the most common reason doctors were reluctant to intervene in addiction was the institutional environment. Authors of the study […]

Rethinking Autism Interventions: More Isn’t Always Better

More intervention hours may not always lead to improved outcomes for children with autism. That’s according to a new meta-analysis published in JAMA today. Researchers analyzed data from 144 studies of early childhood autism interventions, which included a total of 9038 children. “There is not robust evidence that the benefits of early childhood interventions to […]

Buprenorphine Prescribing Gaining Ground at Community Health Centers

In case you missed it, Behavioral Health Business has launched a new specialty publication for professionals in the substance use disorder space. You can subscribe to Addiction Treatment Business here: Subscribe today! Prescriptions for buprenorphine, a medication-assisted-treatment (MAT) used to treat opioid use disorder, are increasing at community health centers (CHCs).  New research published in […]

Telehealth-Focused Practices Offer Medicare Patients With SMI 13% More Visits

During the pandemic, Medicare patients with serious mental illness who accessed care at practices that mainly used telehealth had 13% more mental health visits than those mainly receiving in-person care. However, researchers found no changes in these patients’ medication adherence, hospital and emergency department use or mortality, according to a recent study published in JAMA. […]

Substance Use Disorders Cost Employer-Sponsored Health Plans $35B Per Year

Substance use disorders (SUD) cost employer-sponsored health plans about $35.3 billion per year. That’s according to a new JAMA study, which looked at the cost associated with 162 million non-Medicare eligible members with employer-sponsored health insurance in 2018. Researchers reported that of that 162 million, 2.3 million (1.4%) enrollees had a SUD diagnosis. The study […]

Telehealth OUD Treatment Just as Effective for Pregnant Women as In-Person Assistance

As telehealth services become a more widely available and accepted form of treatment, providers may find it useful in treating pregnant women battling opioid use disorder (OUD). In fact, OUD telemedicine treatment can be just as productive and successful as treatment patients might otherwise get in a clinic, new findings suggest. The study was published […]

MAT with Buprenorphine, Methadone Superior to Other OUD Treatments in Preventing Overdoses

Medication-assisted treatment (MAT) with buprenorphine or methadone is the gold standard for treating individuals with opioid use disorder (OUD), a new study suggests. Compared to other methods of treatment, researchers discovered that when buprenorphine or methadone are administered to individuals with OUD as part of their MAT regimen, they are less likely to experience an […]

Medicaid Expansion Associated with Fewer Fatal Opioid Overdoses

Medicaid expansion could be credited with saving the lives of thousands from opioid overdoses, researchers assert in a new study. In fact, states that adopted Medicaid expansion between 2014 and 2016 recorded fewer opioid-related deaths than states that did not, according to results published by JAMA Network Open. Medicaid expansion was born out of the […]

Beneficiaries Likely to Spend More, Go Out of Network for Behavioral Health Services

Despite the push for parity, Americans are more likely to go out of network and pay higher out-of-pocket costs for behavioral health care treatment than for treatment of chronic conditions such as diabetes and congestive heart failure.  That’s according to research out of Ohio State University published in JAMA Network Open.  The findings illustrate the […]